Skip to main content
Top
Published in: Journal of General Internal Medicine 10/2019

01-10-2019 | Hypertension | Concise Research Reports

The Cardiovascular Health Burdens of Solitary Confinement

Authors: Brie A. Williams, MD, MS, Amanda Li, BA, Cyrus Ahalt, MPP, Pamela Coxson, PhD, James G. Kahn, MD, MPH, Kirsten Bibbins-Domingo, PhD, MD, MAS

Published in: Journal of General Internal Medicine | Issue 10/2019

Login to get access

Excerpt

The American Medical Association recently called for the elimination of solitary confinement for the mentally ill, citing its mental health harms.1 In solitary confinement, people are held in a prison cell roughly the size of a parking space for ~ 22–23 h per day with 1 or 2 h of exercise, also in isolation.2 Although the living conditions in these units (e.g., limited exercise, extreme loneliness) are known risk factors for adverse physical health outcomes including cardiovascular disease,2 the lifetime cardiovascular burden of solitary confinement is unknown. …
Literature
Metadata
Title
The Cardiovascular Health Burdens of Solitary Confinement
Authors
Brie A. Williams, MD, MS
Amanda Li, BA
Cyrus Ahalt, MPP
Pamela Coxson, PhD
James G. Kahn, MD, MPH
Kirsten Bibbins-Domingo, PhD, MD, MAS
Publication date
01-10-2019
Publisher
Springer International Publishing
Published in
Journal of General Internal Medicine / Issue 10/2019
Print ISSN: 0884-8734
Electronic ISSN: 1525-1497
DOI
https://doi.org/10.1007/s11606-019-05103-6

Other articles of this Issue 10/2019

Journal of General Internal Medicine 10/2019 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.